T2 Biosystems, Inc. (LON:0A57)
London · Delayed Price · Currency is GBP · Price in USD 0.1500
+0.0145 (10.70%)
At close: Jun 6, 2025
T2 Biosystems Company Description
T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare.
Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.
T2 Biosystems, Inc.
| Country | United States |
| Founded | 2006 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 113 |
| CEO | Craig Jalbert |
Contact Details
Address: 101 Hartwell Avenue Lexington, Massachusetts 02421 United States | |
| Phone | 781 761 4646 |
| Website | investors.t2biosystems.com |
Stock Details
| Ticker Symbol | 0A57 |
| Exchange | London Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Craig Jalbert | Chief Executive Officer |